CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2018
Operating Activities
Net income	$ 1,120	$ 255	$ 297
Adjustments to reconcile to net cash provided by operating activities:
Depreciation	321	317	303
Amortization	601	632	648
Gain on Healthcare Technology Net Asset Exchange, net	0	0	(37)
Goodwill and other asset impairment charges	139	2,079	2,217
Equity earnings and charges from investment in Change Healthcare Joint Venture	1,084	194	248
Deferred taxes	(342)	189	(868)
Credits associated with last-in, first-out inventory method	(252)	(210)	(99)
Non-cash operating lease expense	366
Loss (gain) from sales of businesses and investments	33	(86)	(169)
Other non-cash items	615	52	67
Changes in assets and liabilities, net of acquisitions:
Receivables	(2,494)	(967)	1,175
Inventories	(376)	(368)	(458)
Drafts and accounts payable	3,952	1,976	271
Operating lease liabilities	(377)
Taxes	(8)	(95)	671
Other	(8)	68	79
Net cash provided by operating activities	4,374	4,036	4,345
Investing Activities
Payments for property, plant and equipment	(362)	(426)	(405)
Capitalized software expenditures	(144)	(131)	(175)
Acquisitions, net of cash, cash equivalents and restricted cash acquired	(133)	(905)	(2,893)
Other	23	(20)	(20)
Net cash used in investing activities	(579)	(1,381)	(2,993)
Financing Activities
Proceeds from short-term borrowings	21,437	37,265	20,542
Repayments of short-term borrowings	(21,437)	(37,268)	(20,725)
Proceeds from issuances of long-term debt	0	1,099	1,522
Repayments of long-term debt	(298)	(1,112)	(2,287)
Payments for debt extinguishments	0	0	(112)
Common stock transactions:
Issuances	113	75	132
Share repurchases, including shares surrendered for tax withholding	(1,954)	(1,639)	(1,709)
Dividends paid	(294)	(292)	(262)
Other	(301)	(355)	(185)
Net cash used in financing activities	(2,734)	(2,227)	(3,084)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(19)	(119)	150
Net increase (decrease) in cash, cash equivalents and restricted cash	1,042	309	(1,582)
Cash, cash equivalents and restricted cash at beginning of year	2,981	2,672	4,254
Cash, cash equivalents and restricted cash at end of year	4,023	2,981	2,672
Cash paid for:
Interest, net	235	383	298
Income taxes, net of refunds	368	262	144
Businesses and investments
Investing Activities
Proceeds from sale of businesses and investments, net and Payments received on Healthcare Technology Net Asset Exchange, net	37	101	374
Healthcare Technology Net Asset Exchange
Adjustments to reconcile to net cash provided by operating activities:
Gain on Healthcare Technology Net Asset Exchange, net	0	0	(37)
Investing Activities
Proceeds from sale of businesses and investments, net and Payments received on Healthcare Technology Net Asset Exchange, net	$ 0	$ 0	$ 126